Mydecine Innovations Group (MYCO.C) psilocybin work with NeuroPharm is a step towards creating a better world

July 16, 2020 by Joseph MortonNeuroPharm War is a part of human nature. It’s the greatest driver of human innovation, and if we’re inclined to be cynical we could state that it’s the key reason our civilization is advanced as it is. If it weren’t for the catalyst of hundreds of years of continuous war, including the prospect of mutually assured […]

Roadman Investments (LITT.V) really doesn’t want to talk about cedar leaf oil anymore

June 26, 2020 by Joseph Morton One of Roadman Investments (LITT.V) subsidiaries, CLOV Biopharma, recently completed its research program at UBC on cedar leaf oil vapour, but the Securities Exchange Commission (SEC) doesn’t care. The research program has taken a bit longer than the company would have liked, courtesy of COVID-19, but the company’s doctors have acquired most of the exemptions […]

EGF Theramed (TMED.C) bought some assets, then spent $700k on dumb promo that hooped their stock

June 18, 2020 by Chris Parry   The big knock on shroom companies in the public markets right now is that most of them are chancers rather than pioneers – markets guys looking to acquire any asset that could convince a psychedelics investor to toss coin at their stock. The track record of EGF Theramed (aka Theramed, aka Evatrade Health, aka […]


HAVN Life Sciences (HAVN.C) supplies mushrooms for Revive Therapeutics (RVV.C) clinical trials

October 21, 2020 by Joseph Mortonclinical Revive Therapeutics (RVV.C) recent supply agreement with HAVN Life Sciences (HAVN.C) will give them a steady supply of naturally derived psychedelic compounds, like psilocybin, to be used in any future investigational new drug (IND) enabling studies and clinical trials under the watchful eye of the U.S. Food and Drug Administration (FDA). HAVN Life Sciences focuses […]

Mind Medicine (MMED.E) and NYU Langone Health are raising money for psychedelics clinical trial

October 8, 2020 by Joseph MortonNYU Mind Medicine (MMED.E) is raising money to found and launch a clinical training program focused on developing psychedelic-assisted therapies and medicines at New York University’s (NYU) Langone Health. The company intends the NYU Langone Health psychedelic medicine research program to be the first step in a large initiative wherein they hope to establish a centre […]

Nutritional High (EAT.C) aims their Psychedelic Science Corporation at prevailing health issues, like insomnia

September 29, 2020 by Joseph MortonInsomnia Deep down the insomnia rabbit hole you can hear of some fairly strange recipes for relief. You’ve got your usuals—melatonin pills, valerian root, chamomile tea, CBD—and believe me when I say I’ve tried them all. Periodically, you’ll hear about some border on the superstitious, such as a boiled rabbits foot served as an infusion is […]

Pharmadrug (BUZZ.C) subsidiary Super Smart’s new Amsterdam locations to focus on customer education

September 23, 2020 by Joseph MortonSuper Smart Pharmadrug’s (BUZZ.C) subsidiary Interrobang, itself doing business as Super Smart, closed the transaction to acquire a brick and mortar store specializing in selling psychedelic products today. This deal had previously been announced on August 14, 2020, and was originally intended to close around the end of that month, but had experienced setbacks due to the […]